Your browser doesn't support javascript.
loading
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer.
Torres-Guzmán, Raquel; Calsina, Bruna; Hermoso, Ana; Baquero, Carmen; Alvarez, Beatriz; Amat, Joaquín; McNulty, Ann M; Gong, Xueqian; Boehnke, Karsten; Du, Jian; de Dios, Alfonso; Beckmann, Richard P; Buchanan, Sean; Lallena, María José.
Affiliation
  • Torres-Guzmán R; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • Calsina B; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • Hermoso A; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • Baquero C; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • Alvarez B; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • Amat J; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • McNulty AM; Oncology Research, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Gong X; Oncology Research, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Boehnke K; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
  • Du J; Oncology Research, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • de Dios A; Discovery Chemistry, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Beckmann RP; Oncology Research, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Buchanan S; Oncology Research, Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Lallena MJ; Quantitative Biology, Eli Lilly and Company, Madrid, Spain.
Oncotarget ; 8(41): 69493-69507, 2017 Sep 19.
Article in En | MEDLINE | ID: mdl-29050219

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Affiliation country: Spain Country of publication: United States